PHAT - Financial Reports List - Phathom Pharmaceuticals, Inc. - IntrinsicAlpha

Phathom Pharmaceuticals, Inc. PHAT

Healthcare - Biotechnology - NASDAQ - US

$ 3.9

-3.23 %

$ 272 M

Market Cap

-0.74

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	4249.56%	6.43%	14.97%
Annual Report	FY	10-K	2024-12-31	8001.47%	-65.84%	-65.84%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-97.90%	-98.54%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-123.23%	-143.84%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-119.10%	-132.58%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-25.40%	-49.81%
Annual Report	FY	10-K	2023-12-31	0.00%	9.60%	2.97%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	27.51%	16.15%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	19.55%	30.12%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	12.92%	20.65%

1